Xeris Biopharma Holdings Inc (XERS)
Operating Expenses
$242.95M
TTM · Period ending: · USD
XERS Operating Expenses
Latest reported$242.95Mperiod ending
Latest reported$242.95Mperiod ending
XERS Operating Expenses ($14.30M → $242.95M)
Annual operating expenses
High-resolution chart · PNG
XERS operating expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Expenses (USD) |
|---|---|
| 213,537,000 | |
| 199,884,000 | |
| 179,279,000 | |
| 169,554,000 | |
| 151,428,000 | |
| 94,653,000 | |
| 123,499,000 | |
| 61,767,000 | |
| 28,181,000 | |
| 14,298,000 |